The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Imaverol 100 mg/ml Concentrate for Cutaneous Emulsion


Main Information

Trade NameImaverol 100 mg/ml Concentrate for Cutaneous Emulsion
Active SubstancesEnilconazole
Dosage FormCutaneous emulsion
Licence HolderAUDEVARD
Licence NumberVPA10481/001/001

Group Information

ATC CodeQD01AC90 enilconazole
Therapeutic ClassAntifungal


License statusAuthorised
Licence Issued30/09/2009
Legal StatusLM: Licensed Merchant as defined in relevant national legislation


Summary of Product Characteristics *PDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
VariationsNo document available

* The PDF document, together with the national-specific product information on this page, constitute the authorised SPC
« Back